GAM
TERN

Gotham Asset Management’s Terns Pharmaceuticals TERN Stock Holding History

Gotham Asset Management’s Portfolio TERN Stock Details TERN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$870K Buy
16,497
+5,021
+44% +$206K ﹤0.01% 1352
2025
Q4 		$464K Buy
+11,476
New +$265K ﹤0.01% 1463

Other funds holding TERN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

Gotham Asset Management's TERN Position: Q1 2026 in Review

Gotham Asset Management increased its Terns Pharmaceuticals (TERN) stake by 44% in Q1 2026, buying an estimated $206K and bringing the position to 16,497 shares worth $870K. The position accounts for ﹤0.01% of the portfolio, ranked #1352.

Gotham Asset Management first reported a position in TERN in Q4 2025 and has held it in 2 quarters since. 317 funds tracked by Wall St. Rank hold TERN as of Q1 2026.

  • Gotham Asset Management held 16,497 shares of Terns Pharmaceuticals worth $870K as of Q1 2026.
  • Gotham Asset Management bought 5,021 Terns Pharmaceuticals shares in Q1 2026, an estimated $206K.
  • Terns Pharmaceuticals made up ﹤0.01% of Gotham Asset Management's portfolio in Q1 2026, its #1352 holding.
  • Gotham Asset Management first reported a position in Terns Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 317 funds tracked by Wall St. Rank held Terns Pharmaceuticals as of Q1 2026.

Based on Gotham Asset Management's 13F filing for Q1 2026, filed 15 May 2026.